<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM60606"><item key="TREATMENT">4&#8242;-iodo-3,3,5-tripropyl-4-methoxy</item></item></item><item><item key="GSM606062"><item key="TREATMENT">control</item></item></item></item><item key="id">3829</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">In our continuing study of the desmosdumotin C (1) series, twelve new analogues, 21&#8211;32, mainly with A-ring modifications, were prepared...</item><item key="geo_gse_id">E-GEOD-24584</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cancer</item><item>cell</item><item>chromosome</item><item>genome</item><item>line</item><item>lung</item><item>lung cancer</item><item>spindle</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">the-antitumor-mechanism-of-desmosdumotin-c-analog</item><item key="geo_id_plat">E-GEOD-24584_A-AFFY-44</item><item key="name">The antitumor mechanism of Desmosdumotin C Analog</item><item key="created">Sep.15, 2014</item><item key="summary">In our continuing study of the desmosdumotin C (1) series, twelve new analogues, 21&#8211;32, mainly with A-ring modifications, were prepared and evaluated for in vitro anticancer activity against several human tumor cell lines. Among them, the 4&#8242;-iodo-3,3,5-tripropyl-4-methoxy analogue (31) showed significant cytotoxicity against multiple human tumor cell lines with ED50 values of 1.1&#8211;2.8 microM. Elongation of the C-3 and C-5 carbon chains reduced activity relative to propyl substituted analogues; however, activity was still better than that of natural 1. Among analogues with various ether groups on C-4, compounds with methyl (2) and propyl (26) ethers inhibited cell growth of multiple tumor cells lines, while 28 with an iso-butyl ether showed selective cytotoxicity against lung cancer A549 cells (ED50 1.7 microM). The gene expression profiles showed that 3 may modulate the spindle assembly checkpoint (SAC) and chromosome separation, and thus, arrest cells at the G2/M-phase. We used microarrays to elucidate the underlying antitumor mechanism induced by Desmosdumotin C Analog Analogue 3 showed potent cytotoxicity against the highly invasive non-small-cell lung cancer cell line CL1-5 with an ED50 value of 0.11 &#181;M. To determine which genes were differentially expressed upon CL1-5 treatment with analogue 3, the genome-wide mRNA expression profiles of 3-treated cells and control cells were determined using Affymetrix human genome U133 plus 2.0 GeneChip according to the Manufacturer&#8217;s protocols</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24584</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24584/samples/</item></data></biogps>
